Back to today’s briefing

Story perspectives

Yale's Enzyme Therapy Restores Hearing in Mice

7/23/2025

30 4

Summary

Story summary

Yale researchers have made a groundbreaking discovery with a bone-targeted enzyme replacement therapy that successfully restored hearing in mice suffering from ENPP1 deficiency, a rare genetic disorder. This innovative treatment not only normalizes inner ear bone health but also holds promise for patients facing various types of hearing loss related to mineralization issues, igniting hope for future advancements in auditory care.

1 of 1

Story summary

Yale researchers have made a groundbreaking discovery with a bone-targeted enzyme replacement therapy that successfully restored hearing in mice suffering from ENPP1 deficiency, a rare genetic disorder. This innovative treatment not only normalizes inner ear bone health but also holds promise for patients facing various types of hearing loss related to mineralization issues, igniting hope for future advancements in auditory care.